Funding Opportunities Supported by DCTD Programs
| Title | Announcement Number | Expiration Date | Activity Code | Program/Contact |
|---|---|---|---|---|
| Assay Development and Screening for Discovery of Chemical Probes, Drugs or Immunomodulators (Clinical Trial Not Allowed) | PAR-25-153 | July 6, 2026 | R01 | DTP/Suzanne Forry and Connie Sommers |
| Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2024, 2025, and 2026 | PAR-23-284 | September 26, 2026 | P50 | TRP Staff |
| Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed) | PAR-25-325 | September 11, 2027 | U01 | CDP/Lokesh Agrawal and Abhi Rao |
| Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (Clinical Trial Not Allowed) | PAR-24-304 | October 15, 2026 | R01 | CDP/Sumana Dey |
| Assay Validation of High Quality Markers for Clinical Studies in Cancer (Clinical Trial Not Allowed) | PAR-25-074 | October 15, 2026 | UH2/UH3 | CDP/Sumana Dey, CTEP/Minyung Song |
| Assay Validation of High Quality Markers for Clinical Studies in Cancer (Clinical Trial Not Allowed) | PAR-25-075 | October 15, 2026 | UH3 | CDP/Sumana Dey, CTEP/Minyung Song |
| Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (Clinical Trials Optional) | PAR-25-079 | November 6, 2026 | R01 | CIP/Darrell Tata |
| NCI's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (Clinical Trial Required) | PAR-25-081 | November 6, 2026 | R01 | CTEP/Lori A. Henderson, CIP/Lalitha Shankar, RRP/Jeff Buchsbaum, CDP/Magdalena Thurin, OCCAM/Dan Xi |
| Bioengineering Partnerships with Industry (Clinical Trial Optional) | PAR-24-325 | May 28, 2027 | U01 | CDP/Miguel Ossandon |
| Toward Translation of Nanotechnology Cancer Interventions (TTNCI; R01 Clinical Trial Not Allowed) | PAR-25-336 | November 16, 2027 | R01 | CIP NANO/Piotr Grodzinski and Yicong Wu |
| Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (Clinical Trial Optional) | PAR-25-175 | November 6, 2027 | R01 | CIP/Yisong Wang |
| Molecular Imaging of Inflammation in Cancer (Clinical Trial Not Allowed) | PAR-24-311 | November 6, 2027 | R01 | CIP/Charles Lin |
NIH Highlighted Topics Supported by DCTD Programs
| Title | Expiration Date | Program/Contact |
|---|---|---|
| Advancing Nanotechnology Research to Improve Diagnosis and Treatment Options | March 10, 2028 | CIP/Piotr Grodzinski, DTP/Yali Fu |
| Advancing Treatment Options using Targeted Degrader Technologies | March 10, 2028 | DTP/Sundaresan Venkatachalam and William Greenberg |
| Quantum Information Science & Technologies for Biomedical Applications | April 9, 2028 | RRP/Jeff Buchsbaum |
| Advancing Mechanism-driven Translational Research of Beneficial and Detrimental Effect of Psilocybin on Cancer and Other Health Conditions | April 10, 2028 | OCCAM/Dani Xi |
| Computational Modeling of Complex Processes Across Biological Scales | April 17, 2028 | RRP/Jeff Buchsbaum |